project id: TCGA-CESC; case submitter id: TCGA-EK-A2PG; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.0; age at index: 88; days to birth: -32500; ethnicity: not reported; gender: female; race: black or african american; vital status: Alive; year of birth: 1917; age at diagnosis: 32500; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 46.0; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2165; initial weight: 40.0; oct embedded: false; preservation method: Unknown; sample id: b36b549d-2031-47b5-ba70-a3ea88fd5c39; sample submitter id: TCGA-EK-A2PG-01A; portion id: 4680989a-9c75-4569-ab7f-91fa7656cb6b; portion submitter id: TCGA-EK-A2PG-01A-11; slide id: 947e376d-3124-456d-9ca3-0074d9a30492; slide submitter id: TCGA-EK-A2PG-01A-01-TS1; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 29.0; percent stromal cells: 20.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP;